NM
Newtyn Management Portfolio holdings
AUM
$660M
This Quarter Return
-9.54%
1 Year Return
+22.08%
3 Year Return
+41.34%
5 Year Return
+148.8%
10 Year Return
+127.87%
AUM
$455M
AUM Growth
+$455M
(-14%)
Cap. Flow
-$8.14M
Cap. Flow
% of AUM
-1.79%
Top 10 Holdings %
Top 10 Hldgs %
51.9%
Holding
94
New
10
Increased
20
Reduced
27
Closed
14
Top Buys
| 1 |
Sylvamo
SLVM
|
$14.9M |
| 2 |
SAFE
Safehold
SAFE
|
$7.83M |
| 3 |
IAC Inc
IAC
|
$5.54M |
| 4 |
Theravance Biopharma
TBPH
|
$4.64M |
| 5 |
1-800-Flowers.com
FLWS
|
$3.28M |
Top Sells
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$11.1M |
| 2 |
Liquidia Corp
LQDA
|
$6.84M |
| 3 |
Algoma Steel
ASTL
|
$5.85M |
| 4 |
TSVT
2seventy bio
TSVT
|
$5.77M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$3.96M |
Sector Composition
| 1 | Healthcare | 20.49% |
| 2 | Consumer Discretionary | 19.55% |
| 3 | Financials | 13.18% |
| 4 | Real Estate | 9.6% |
| 5 | Technology | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Destination XL Group
DXLG
$70M
| $4.88M | 1.07% |
900,000
| – | – |
|
27
Customers Bancorp
CUBI
$2.24B
| $4.42M | 0.97% |
150,000
| – | – |
|
28
Tilly's
TLYS
$57M
| $3.95M | 0.87% |
571,150
-48,850
| -8% | -$338K |
|
|
29
Algoma Steel
ASTL
$493M
| $3.81M | 0.84% |
590,899
-909,101
| -61% | -$5.85M |
|
30
Stitch Fix
SFIX
$662M
| $3.67M | 0.81% |
929,200
+104,200
| +13% | +$412K |
|
31
Phathom Pharmaceuticals
PHAT
$859M
| $3.5M | 0.77% |
315,975
+60,208
| +24% | +$667K |
|
|
32
1-800-Flowers.com
FLWS
$355M
| $3.28M | 0.72% |
+505,900
| New | +$3.28M |
|
33
uniQure
QURE
$907M
| $3.28M | 0.72% |
175,000
-97,091
| -36% | -$1.82M |
|
|
NXDT
34
NexPoint Diversified Real Estate Trust
NXDT
$184M
| $3.14M | 0.69% |
250,000
| – | – |
|
35
American Express Global Business Travel
GBTG
$3.93B
| $2.92M | 0.64% |
515,400
+270,192
| +110% | +$1.53M |
|
|
ILPT
36
Industrial Logistics Properties Trust
ILPT
$396M
| $2.75M | 0.6% |
+500,000
| New | +$2.75M |
|
|
IVAC
37
DELISTED
Intevac Inc
IVAC
| $2.42M | 0.53% |
520,000
+15,965
| +3% | +$74.2K |
|
38
Wave Life Sciences
WVE
$1.55B
| $2.17M | 0.48% |
600,000
+196,447
| +49% | +$709K |
|
|
DNMR
39
DELISTED
Danimer Scientific, Inc.
DNMR
| $1.84M | 0.4% |
625,000
| – | – |
|
40
89bio
ETNB
$1.37B
| $1.8M | 0.39% |
310,000
| – | – |
|
41
Collegium Pharmaceutical
COLL
$1.25B
| $1.68M | 0.37% |
105,000
| – | – |
|
42
Pyxis Oncology
PYXS
$81.2M
| $1.58M | 0.35% |
800,000
| – | – |
|
43
ATAI Life Sciences
ATAI
$990M
| $1.56M | 0.34% |
470,000
| – | – |
|
44
Comp X International
CIX
$301M
| $1.51M | 0.33% |
93,160
-6,840
| -7% | -$111K |
|
|
ALR
45
DELISTED
AlerisLife Inc. Common Stock
ALR
| $1.43M | 0.31% |
1,500,000
| – | – |
|
|
CYT
46
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $1.26M | 0.28% |
654,112
+47,864
| +8% | +$91.9K |
|
47
CytomX Therapeutics
CTMX
$346M
| $1.16M | 0.25% |
800,000
-273,400
| -25% | -$396K |
|
48
Olema Pharmaceuticals
OLMA
$406M
| $1.1M | 0.24% |
400,000
-100,000
| -20% | -$276K |
|
49
Aligos Therapeutics
ALGS
$73.3M
| $1.1M | 0.24% |
1,000,000
+37,912
| +4% | +$41.7K |
|
50
Invivyd
IVVD
$220M
| $1.1M | 0.24% |
350,000
-50,875
| -13% | -$159K |
|